Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis Of Invasive Fungal Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00095316
What this trial is testing

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Who this might be right for
Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Post-approval studies (Phase 4)Study completedNCT01232504
What this trial is testing

Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT

Who this might be right for
Mycoses
Xiamen Amoytop Biotech Co., Ltd. 206
Testing effectiveness (Phase 2)WithdrawnNCT02856178
What this trial is testing

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Who this might be right for
Pulmonary Aspergillosis - InvasiveAcute Myeloid Leukemia
F2G Ltd
Not applicableEnrolling By InvitationNCT06698211
What this trial is testing

Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD

Who this might be right for
Invasive Fungal DiseaseGraft Versus Host DiseaseHematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 40
Early research (Phase 1)Study completedNCT00005912
What this trial is testing

Voriconazole to Prevent Systemic Fungal Infections in Children

Who this might be right for
AspergillosisCandidiasisFungal Diseases+1 more
National Cancer Institute (NCI) 48
Not applicableNot Yet RecruitingNCT07559032
What this trial is testing

Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients

Who this might be right for
Invasive Fungal Disease
Peking University People's Hospital 15
Not applicableStudy completedNCT03174457
What this trial is testing

Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

Who this might be right for
Invasive Fungal Infections
Astellas Pharma Singapore Pte. Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT02172768
What this trial is testing

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAllogeneic Stem Cell TransplantAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06541067
What this trial is testing

Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI)

Who this might be right for
Hematologic Malignancy
Nantes University Hospital 30
Large-scale testing (Phase 3)UnknownNCT01974375
What this trial is testing

Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

Who this might be right for
Liver Transplant Recipient
Asan Medical Center 172
Testing effectiveness (Phase 2)Study completedNCT01249820
What this trial is testing

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Who this might be right for
LeukemiaMyelodysplastic SyndromeLeukemia, Myeloid, Acute
Radboud University Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00501098
What this trial is testing

Prophylaxis of Fungal Invasive Infections in Leukemia

Who this might be right for
Invasive Pulmonary Aspergillosis
Northern Italy Leukemia Group 100
Testing effectiveness (Phase 2)UnknownNCT00451711
What this trial is testing

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 60
Testing effectiveness (Phase 2)UnknownNCT00333645
What this trial is testing

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

Who this might be right for
Liver TransplantationFungal Infection
Grupo de Estudio de Infecciones en Transplantados 70
Testing effectiveness (Phase 2)Looking for participantsNCT07215273
What this trial is testing

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

Who this might be right for
Invasive Mould Infection
Elion Therapeutics, Inc. 60
Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Large-scale testing (Phase 3)Study completedNCT00027248
What this trial is testing

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

Who this might be right for
SepsisBacteremiaFungemia
BioWest Therapeutics Inc 1,400
Large-scale testing (Phase 3)Study completedNCT00263315
What this trial is testing

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Who this might be right for
Aspergillosis
Erasmus Medical Center 320
Not applicableUnknownNCT05130723
What this trial is testing

Pharmacokinetics of Fluconazole in Children (2-18 Years)

Who this might be right for
Invasive Fungal Infections
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT01075984
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)

Who this might be right for
Fungal Infection
Merck Sharp & Dohme LLC 279
Next Page